Gerrit Kann

1.3k total citations
21 papers, 673 citations indexed

About

Gerrit Kann is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Gerrit Kann has authored 21 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Gerrit Kann's work include Viral Infections and Outbreaks Research (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Gerrit Kann is often cited by papers focused on Viral Infections and Outbreaks Research (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Gerrit Kann collaborates with scholars based in Germany, United Kingdom and Ireland. Gerrit Kann's co-authors include Timo Wolf, Markus Eickmann, Maria J. G. T. Vehreschild, René Gottschalk, Annemarie Berger, Boris Böddinghaus, Marhild Kortenbusch, Peter J. Neumann, Sebastian Hoehl and Udo Götsch and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Gerrit Kann

20 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerrit Kann Germany 9 471 117 98 91 77 21 673
Susan Ahern Ireland 9 385 0.8× 74 0.6× 71 0.7× 29 0.3× 43 0.6× 22 565
Shazaad Ahmad United Kingdom 12 302 0.6× 96 0.8× 81 0.8× 20 0.2× 41 0.5× 25 481
Jonggul Lee South Korea 10 278 0.6× 281 2.4× 75 0.8× 25 0.3× 29 0.4× 16 570
Angela Stein Germany 10 394 0.8× 86 0.7× 167 1.7× 16 0.2× 40 0.5× 14 633
Dianne Egli-Gany Switzerland 14 469 1.0× 309 2.6× 240 2.4× 17 0.2× 66 0.9× 16 1.1k
Marhild Kortenbusch Germany 5 348 0.7× 100 0.9× 76 0.8× 8 0.1× 63 0.8× 8 537
David Leeman United Kingdom 8 521 1.1× 81 0.7× 43 0.4× 25 0.3× 94 1.2× 15 693
Sana Chams United States 7 198 0.4× 43 0.4× 76 0.8× 17 0.2× 51 0.7× 8 473
Robert Dyrdak Sweden 13 319 0.7× 111 0.9× 174 1.8× 11 0.1× 34 0.4× 16 621
Udo Götsch Germany 5 303 0.6× 104 0.9× 38 0.4× 10 0.1× 62 0.8× 6 448

Countries citing papers authored by Gerrit Kann

Since Specialization
Citations

This map shows the geographic impact of Gerrit Kann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Kann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Kann more than expected).

Fields of papers citing papers by Gerrit Kann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Kann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Kann. The network helps show where Gerrit Kann may publish in the future.

Co-authorship network of co-authors of Gerrit Kann

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit Kann. A scholar is included among the top collaborators of Gerrit Kann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit Kann. Gerrit Kann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldauf, Hanna‐Mari, Stefan Stein, Gerrit Kann, et al.. (2022). HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo. Cells. 11(19). 2968–2968. 11 indexed citations
2.
Wetzstein, Nils, Gerrit Kann, Gundolf Schüttfort, et al.. (2021). Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study. PLoS ONE. 16(7). e0254607–e0254607. 9 indexed citations
3.
Schuettfort, Gundolf, Alfonso Cabello, Aoife G. Cotter, et al.. (2021). Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in Europe. AIDS Patient Care and STDs. 35(4). 110–115. 9 indexed citations
4.
Kann, Gerrit, Annette Haberl, Timo Wolf, et al.. (2021). Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study. HIV/AIDS - Research and Palliative Care. Volume 13. 789–800. 1 indexed citations
5.
Kann, Gerrit, Nils Wetzstein, Gundolf Schuettfort, et al.. (2021). Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation. Journal of Infection. 83(3). 347–353. 4 indexed citations
6.
Schüttfort, Gundolf, Gerrit Kann, Christoph Königs, et al.. (2020). Influence of tenofovir exposure in utero on primary dentition. European Journal of Pediatrics. 179(11). 1761–1768. 3 indexed citations
7.
Hoehl, Sebastian, Holger F. Rabenau, Annemarie Berger, et al.. (2020). Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. New England Journal of Medicine. 382(13). 1278–1280. 403 indexed citations
8.
Schuettfort, Gundolf, Alfonso Cabello, Philipp de Leuw, et al.. (2020). Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors. HIV Medicine. 22(1). 47–53. 12 indexed citations
9.
Wetzstein, Nils, Gerrit Kann, Michael Hogardt, et al.. (2019). Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest. International Journal of Infectious Diseases. 84. 116–120. 8 indexed citations
10.
Wetzstein, Nils, Thomas A. Wichelhaus, Michael Hogardt, et al.. (2019). Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006–2016. Infection. 47(5). 817–825. 8 indexed citations
11.
Schüttfort, Gundolf, K Philipp, Philipp de Leuw, et al.. (2019). Sex and Gender Differences in Rilpivirine based ART - Data from the HIVCENTER Frankfurt. Current HIV Research. 17(5). 368–374. 1 indexed citations
12.
13.
Wolff, Svenja, Tilman Schultze, Sarah Katharina Fehling, et al.. (2016). Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany. Genome Announcements. 4(5). 15 indexed citations
14.
Biedenkopf, Nadine, Tilman Schultze, Gopala Krishna Mannala, et al.. (2016). Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing. Genome Announcements. 4(5). 1 indexed citations
15.
16.
Quick‐Weller, Johanna, Gerrit Kann, Stephanie Lescher, et al.. (2015). Impact of Stereotactic Biopsy in HIV Patients. World Neurosurgery. 86. 300–305. 6 indexed citations
17.
Hogardt, Michael, Timo Wolf, Gerrit Kann, et al.. (2015). Commentary: Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations. Journal of Clinical Microbiology. 53(11). 3396–3400. 5 indexed citations
18.
Wieters, Imke, Gerrit Kann, Siri Goepel, et al.. (2014). Autologous stem cell transplantation in HIV‐related lymphoma in the rituximab era – a feasibility study in a monocentric cohort. Journal of the International AIDS Society. 17(4S3). 19648–19648. 2 indexed citations
19.
Wolf, Timo, Gerrit Kann, Stephan Becker, et al.. (2014). Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. The Lancet. 385(9976). 1428–1435. 154 indexed citations
20.
Wolf, Timo, J. Atta, Christoph Stephan, et al.. (2014). Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation. Infection. 42(2). 445–447. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Ahern Breakdown of academic impact, for papers by Shazaad Ahmad Breakdown of academic impact, for papers by Jonggul Lee Breakdown of academic impact, for papers by Angela Stein Breakdown of academic impact, for papers by Dianne Egli-Gany Breakdown of academic impact, for papers by Marhild Kortenbusch Breakdown of academic impact, for papers by David Leeman Breakdown of academic impact, for papers by Sana Chams Breakdown of academic impact, for papers by Robert Dyrdak Breakdown of academic impact, for papers by Udo Götsch
Rankless by CCL
2026